NEUWAY Pharma
Ludwig-Erhard-Allee 2
Bonn
5317
Germany
Tel: 49-0-228-522798-0
Fax: 49-0-228-522798-99
Website: http://www.neuway-pharma.com/
Email: info@neuway-pharma.com
About NEUWAY Pharma
NEUWAY: focuses on the preclinical and clinical development of innovative therapeutics for treatment of severe orphan brain diseases based on its proprietary CNS Drug Delivery Platform.YEAR FOUNDED:
April 2014
LEADERSHIP:
Founder and CEO: Stephan Rapp
Founder and CSO: Heiko Manninga
COO: Rudi Scherhag
5 articles about NEUWAY Pharma
-
NEUWAY Pharma Appoints Dr Oliver Ernst as Chief Executive Officer and Dr Thomas Christoph as Chief Development Officer
9/20/2022
NEUWAY Pharma GmbH announced two new appointments in its senior leadership team: Dr Oliver Ernst, formerly NEUWAY's Chief Operating Officer, was promoted to Chief Executive Officer, and Dr Thomas Christoph was appointed as new Chief Development Officer.
-
NEUWAY Pharma Appoints Healthcare Sector Veteran Dr Jacques Mallet to its Advisory Board
9/9/2022
NEUWAY Pharma GmbH announced the appointment of Dr Jacques Mallet as an additional independent member of the Advisory Board.
-
BioSpace Movers & Shakers, July 9
7/9/2021
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers. -
NEUWAY Pharma Announces Formation of Scientific Advisory Board
7/6/2021
NEUWAY Pharma announced the formation of its Scientific Advisory Board including leading drug delivery and drug development experts Hans Grünhagen, Olaf Ritzeler, and Georg Terstappen.
-
NEUWAY Pharma And Cobra Biologics Ltd. Collaborate To Develop GMP Grade Engineered Protein Capsules (EPCs) Manufacturing Process
10/11/2016